Jubilant Life Sciences is currently trading at Rs. 526.00, up by 9.20 points or 1.78% from its previous closing of Rs. 516.80 on the BSE.
The scrip opened at Rs. 520.05 and has touched a high and low of Rs. 534.35 and Rs. 518.15 respectively. So far 14891 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 1 has touched a 52 week high of Rs. 898.00 on 18-Mar-2019 and a 52 week low of Rs. 392.30 on 26-Aug-2019.
Last one week high and low of the scrip stood at Rs. 540.75 and Rs. 489.00 respectively. The current market cap of the company is Rs. 8373.41 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 29.81% and 19.52% respectively.
Jubilant Life Sciences has paid the penalty of Rs 5 lakh pursuant to the Securities Appellate Tribunal (SAT) Order on November 22, 2019.
SAT had reduced the penalty on Jubilant Life Sciences to Rs 5 lakh, levied by markets regulator SEBI for violating norms pertaining to price-sensitive information. Earlier, the regulator had imposed a fine of Rs 10 lakh on the firm in January 2018 for making delayed disclosure to the exchanges on various instances regarding price-sensitive information.
Earlier, the regulator had imposed a fine of Rs 10 lakh on the firm in January 2018 for making delayed disclosure to the exchanges on various instances regarding price-sensitive information.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.